Chihiro Hosoya, Head of Venture Management and Business Development of Rx+ Business of Astellas.
Astellas is a pharmaceutical company and VISION is to stand on the forefront of healthcare change to turn innovative science into VALUE for patients. Chihiro’s responsibility is to seek investment and partnership opportunities in Rx+® initiative, which seeks new healthcare solution beyond medicine. One of three value propositions of Rx+ includes “expand options for people with limited access to current therapeutics”. In the meeting, she would like to meet and understand novel technologies that can contribute to such value proposition.